Pfizer (PFE): Rep. Lisa C. McClain (MI09) disclosed a purchase $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

28 days

Disclosure lag

Traded

Jul 16, 2025

Disclosed

Aug 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 15, 2025CongressDisclosed purchase of PFE — reported range $15,001 - $50,000
2. May 28, 2025FDARecall: DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy,…
3. May 30, 2025CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
4. Jun 3, 2025Congress · 2 peopleMembers of Congress: 2 sales
5. Jun 12, 2025FDAFDA drug approval: Talzenna
6. Jun 12, 2025FDAFDA drug approval: Talzenna
7. Jul 10, 2025FDAFDA drug approval: Elrexfio
8. Jul 10, 2025FDARecall: Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made…
9. Jul 10, 2025FDARecall: Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made…
10. Jul 16, 2025 · this disclosureCongressDisclosed purchase of PFE — reported range $1,001 - $15,000

What came next

1. Jul 29, 2025FDARecall: Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851…
2. Aug 4, 2025FDARecall: Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 04…
3. Aug 4, 2025FDARecall: Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 004…
4. Aug 4, 2025CongressDisclosed sale of PFE — reported range $1,001 - $15,000
5. Aug 5, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
6. Aug 25, 2025Layoff notice · BothellLayoff notice filed in WA: 100 employees
7. Sep 11, 2025FDAFDA drug approval: Potassium Phosphates
8. Sep 16, 2025FDAFDA drug approval: Ibrance
9. Sep 16, 2025FDAFDA drug approval: Ibrance
10. Oct 16, 2025FDAFDA drug approval: Xeljanz
11. Nov 4, 2025Company filing · Form 8-K · ResultsReported its results

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Pfizer

OQRO holds no insider, Congress, fund or contract record for Pfizer dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.

Other recent filings by Rep. Lisa C. McClain (MI09)

• House Clerk periodic transaction report at CACI (CACI)Oct 12, 2026
• House Clerk periodic transaction report at Caterpillar (CAT)Oct 12, 2026
• House Clerk periodic transaction report at Immunitybio (IBRX)Oct 12, 2026
• House Clerk periodic transaction report at Immunitybio (IBRX)Oct 12, 2026
• House Clerk periodic transaction report at Microsoft (MSFT)Oct 12, 2026

The full history of Rep. Lisa C. McClain (MI09) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Pfizer

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its PFE page.